![Salim Dhanji](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Salim Dhanji
Chief Executive Officer at
ME THERAPEUTICS HOLDINGS INC.
Net worth: 7 M $ as of 31/05/2026
Profile
Salim Zulifkar Dhanji is President, Chief Executive Officer & Director at ME Therapeutics Holdings, Inc. since 2023.
Dr. Dhanji is President at Perceptive Property Development since 2013.
Formerly, Dr. Dhanji was Director-Preclinical Research at Qu Biologics, Inc. from 2009 to 2014.
Education includes an undergraduate degree (2001) and a doctorate (2006) from the University of British Columbia.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 4,175,143 ( 13.89% ) | 7 M $ | 31/05/2026 |
Salim Dhanji active positions
| Companies | Position | Start |
|---|---|---|
| ME THERAPEUTICS HOLDINGS INC. | Chief Executive Officer | 09/03/2023 |
Former positions of Salim Dhanji
| Companies | Position | End |
|---|---|---|
Qu Biologics, Inc.
 Qu Biologics, Inc. BiotechnologyHealth Technology Develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer | Corporate Officer/Principal | 01/01/2014 |
Training of Salim Dhanji
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
98
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer | Health Technology |
ME Therapeutics Holdings, Inc.
 ME Therapeutics Holdings, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical services | Health Technology |
- Stock Market
- Insiders
- Salim Dhanji
